• DOI:10.1016/S1474-4422(08)70295-3
Corpus ID: 23000439

The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial

@article{Ballard2009TheDA,
  title={The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial},
  author={C. Ballard and M. Hanney and M. Theodoulou and S. Douglas and F. T. investigators},
  journal={The Lancet Neurology},
  year={2009},
  volume={8},
  pages={151-157}
}

• C. Ballard, M. Hanney, +2 authors F. T. investigators
• Published 2009
• Medicine
• The Lancet Neurology

BACKGROUND Data from 12-week placebo-controlled trials have led to mounting concerns about increased mortality in patients with Alzheimer's disease (AD) who are prescribed antipsychotics; however, there are no mortality data from long-term placebo-controlled trials. We aimed to assess whether continued treatment with antipsychotics in people with AD is associated with an increased risk of mortality. METHODS Between October, 2001, and December, 2004, patients with AD who resided in care… Expand

View on Elsevier

doi.org

Save to Library

Create Alert

Cite

Launch Research Feed